The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial launch generated significant profits, the end of its patent opened the avenue to generic competitors, https://woodyviul030193.mybuzzblog.com/21909274/the-copyright-and-the-pharmaceutical-industry-a-precarious-opportunity